Feb 2, 2026 08:03AM
Feb 2, 2026 08:00AM
Dec 22, 2023 04:30PM
Jun 22, 2023 08:00AM
Apr 28, 2023 09:44AM
Mar 3, 2023 07:30AM
Mar 3, 2023 07:30AM Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma
Mar 3, 2023 07:30AM
Sep 30, 2022 07:42PM
Jul 25, 2022 11:07PM
May 2, 2022 08:00AM
Apr 29, 2022 04:00PM
Jan 20, 2022 08:03AM
Jan 20, 2022 08:00AM Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma
Jan 10, 2022 08:00AM
Sep 15, 2021 08:00AM
Sep 15, 2021 08:00AM
May 24, 2021 08:08AM
May 24, 2021 08:00AM
Apr 19, 2021 07:00AM
Jan 20, 2021 09:20AM Pre-Open Stock Movers 01/20: (APM) (EVLO) (NFLX) Higher; (GEVO) (HSTO) (BLRX) Lower (more...)
Sep 1, 2020 06:05AM
Sep 1, 2020 06:02AM
Sep 1, 2020 03:41AM
Sep 1, 2020 03:32AM
Sep 1, 2020 03:20AM
Sep 1, 2020 02:00AM
Sep 1, 2020 02:00AM Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA Bacteraemia against Linezolid and Vancomycin Respectively in In Vivo Models
Sep 1, 2020 02:00AM
Sep 1, 2020 02:00AM
Sep 1, 2020 02:00AM
Sep 1, 2020 02:00AM
Apr 29, 2020 08:00AM
Feb 10, 2020 10:10AM
Feb 10, 2020 08:58AM Aptorum Group Announces Significant Progress of Repurposed Drug Candidate, SACT-1 for Neuroblastoma Targeting IND Submission in H2 2020
Feb 10, 2020 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All